Breast Cancer Clinical Trial
Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy
Summary
Accelerated Partial Breast Irradiation by Mammosite and intensity modulated radiotherapy is safe and effective in patients with early stage breast cancer resected by lumpectomy.
Eligibility Criteria
Inclusion Criteria:
Be a Tis, T1, N0, M0 AJC Classification
Have negative surgical margins (> or = 2 mm) after final surgery
Should have adequate skin spacing between balloon surface and surface the skin (> 7 mm)*
Patients with infiltrating lobular histologies should have breast MRI scanning as part of the initial staging to verify localized T1, or Tis disease
Multifocal findings (define as 2 or more breast quadrants) on MRI scanning should be further evaluated by ultrasound and, if necessary biopsy, to exclude multiquadrant disease.
Exclusion Criteria:
Be pregnant or breast-feeding
Have collagen-vascular disease
Inadequate surgical margins (< 2 mm)
Patients with malignant/suspicious calcifications
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 6 Locations for this study
Aurora Colorado, 80012, United States
Boulder Colorado, 80303, United States
Denver Colorado, 80128, United States
Littleton Colorado, 80120, United States
Lone Tree Colorado, 80124, United States
Thornton Colorado, 80260, United States
How clear is this clinincal trial information?